This study shows that starting insulin boosts treatment early can help improve biomarkers for low-grade inflammation and endothelial function, both of which are known to show increased cardiovascular risk in people who have just been diagnosed with T2D.
This is very strong proof that early insulin boosts therapy should be the first choice for newly diagnosed patients.
Insulin Boosts
The results were written up in early June in the international magazine of Signal Transduction and Targeted Therapy. This study shows that starting insulin treatment early can help improve biomarkers for low-grade inflammation and endothelial function, both of which are known to show increased cardiovascular risk in people who have just been diagnosed with T2D.
This is very strong proof that early insulin therapy should be the first choice for newly diagnosed patients.
The results were written up in early June in the international magazine of Signal Transduction and Targeted Therapy.
Entertainment7 months ago
